Radiation During Osimertinib Treatment: a Safety and Efficacy Cohort Study

Summary

Study Objectives are: To assess the safety of osimertinib treatment continuation during irradiation therapy for palliation or oligoprogressive disease by assessment of grade 3-5 AEs during and after concomitant osimertinib and irradiation of tumor sites. To assess the efficacy of osimertinib treatment continuation during irradiation therapy for palliation or oligoprogressive disease. To investigate Quality of Life during and after irradiation therapy and concomitant osimertinib.

Timeline

Start

2022-01-20

Primary completion

2026-03

Completion

2027-03

Drugs

Indications